Lamisil Defense Information

What's inside Lamisil Defense

Lamisil Defense in the News

Deutsche Wohnen, Infineon, Leclanche: European Equity Preview - Bloomberg
Novartis AG (NOVN VX): Switzerland's biggest drugmaker won US approval for its antifungal medicine Lamisil, which treats scalp ringworm in children aged 4 ...
Sun Sep 30 22:07:35 -0400 2007

Deutsche Wohnen, Infineon, Leclanche: European Equity Preview - Bloomberg
Novartis AG (NOVN VX): Switzerland's biggest drugmaker won US approval for its antifungal medicine Lamisil, which treats scalp ringworm in children aged 4 ...
Sun Sep 30 22:07:35 -0400 2007

Deutsche Wohnen, Infineon, Leclanche: European Equity Preview - Bloomberg
Novartis AG (NOVN VX): Switzerland's biggest drugmaker won US approval for its antifungal medicine Lamisil, which treats scalp ringworm in children aged 4 ...
Sun Sep 30 22:07:35 -0400 2007

Lamisil Defense Chemical Information

tolnaftate - A thiocarbamate derivative with either fungicidal or fungistatic property. Tolnaftate is a selective, reversible and non-competitive inhibitor of membrane-bound squalene-2,3- epoxidase, an enzyme involved in the biosynthesis of ergosterol. Inhibition leads to the accumulation of squalene and a deficiency in ergosterol, an essential component of fungal cell walls, thereby increasing membrane permeability, disrupting cellular organization and causing cell death. In addition, this agent may also distort the hyphae and stunts mycelial growth in susceptible fungi.